Streetbeat News

Analyst Ratings

CLMB

Barrington Research analyst Vincent Colicchio has reiterated an 'Outperform' rating on Climb Global Solutions (NASDAQ:CLMB) and maintained a $60 price target.

Portfolio Pulse from richadhand@benzinga.com

July 19, 2023 | 1:23 pm

MSFT

B of A Securities analyst Brad Sills maintains a Buy rating on Microsoft (NASDAQ:MSFT) and raises the price target from $340 to $405.

Portfolio Pulse from Benzinga Newsdesk

July 19, 2023 | 1:07 pm

LMT

Lockheed Martin Corp reported better-than-expected Q2 FY23 results with net sales growth of 8.1% YoY to $16.69 billion, above the consensus of $15.91 billion. Adjusted EPS of $6.73 also topped the consensus of $6.45. The company raised its FY23 net sales and EPS forecasts. Despite the strong results, Lockheed Martin shares fell 3% to close at $455.70 on Tuesday. Post-earnings, Citigroup, Wells Fargo, and RBC Capital revised their price targets on Lockheed Martin.

Portfolio Pulse from Lisa Levin

July 19, 2023 | 1:07 pm

LSPD

Over the past 3 months, 14 analysts have published their opinion on Lightspeed Commerce (NYSE:LSPD) stock. The company has an average price target of $19.07, representing a 6.43% decrease from the previous average price target of $20.38. The majority of the analysts are somewhat bullish on the stock.

Portfolio Pulse from Benzinga Insights

July 19, 2023 | 1:01 pm

MDT

In the last quarter, Medtronic (NYSE:MDT) received 2 bullish, 4 somewhat bullish, and 5 indifferent ratings from analysts. The company's average 12-month price target is $95.64, an increase of 7.11% from the previous average of $89.29.

Portfolio Pulse from Benzinga Insights

July 19, 2023 | 1:00 pm

WDC

Over the past 3 months, 11 analysts have published their opinion on Western Digital (NASDAQ:WDC) stock. The company has an average price target of $41.64, a decrease of 2.89% from the previous average price target of $42.88. The majority of the analysts are indifferent about the stock, with 2 bullish, 3 somewhat bullish, and 6 indifferent ratings.

Portfolio Pulse from Benzinga Insights

July 19, 2023 | 1:00 pm

SCPH

Analysts have provided bullish ratings for scPharmaceuticals (NASDAQ:SCPH) in the last quarter. According to 4 analysts offering 12-month price targets in the last 3 months, scPharmaceuticals has an average price target of $18.5, an increase of 42.31% from the previous average price target of $13.00.

Portfolio Pulse from Benzinga Insights

July 19, 2023 | 1:00 pm

WM

Analysts have provided bullish ratings for Waste Management (NYSE:WM) in the last quarter, with 3 bullish, 1 somewhat bullish, and 1 indifferent. The average 12-month price target for WM is $185.6, which has increased by 6.46% over the past month.

Portfolio Pulse from Benzinga Insights

July 19, 2023 | 1:00 pm

UNCY

Analysts have provided bullish ratings for Unicycive Therapeutics (NASDAQ:UNCY) within the last quarter. According to 8 analysts offering 12-month price targets in the last 3 months, Unicycive Therapeutics has an average price target of $5.75, a decrease of 45.24% from the previous average price target of $10.50.

Portfolio Pulse from Benzinga Insights

July 19, 2023 | 1:00 pm

LMT

RBC Capital analyst Ken Herbert has maintained a 'Sector Perform' rating on Lockheed Martin (NYSE:LMT) but lowered the price target from $500 to $475.

Portfolio Pulse from Benzinga Newsdesk

July 19, 2023 | 12:59 pm